BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2007
View Archived Issues
Pooled data show relief of fibromyalgia pain with pregabalin
Read More
Continued efficacy in systemic lupus erythematosus after 1 year with belimumab
Read More
Improvements in renal function with eprodisate in AA amyloidosis seen over 3 years
Read More
Mechanism of neuroprotective effect of NNZ-2256 studied in brain injury model
Read More
Gusperimus active in some patients with SLE-associated glomerulonephritis
Read More
Topiramate demonstrates potential in treating gliomas
Read More
Vegenics licenses antibodies against VEGF-C from CoGenesys
Read More
GlaxoSmithKline outlines planned launches in oncology
Read More
Novel compounds for autoimmune disorders claimed in recent patents
Read More
Enrollment completed in phase III trial of Yondelis for relapsed ovarian cancer
Read More
Geron increases stake in joint venture TA Therapeutics
Read More
Phase I study of HuCNS-SC advances into high-dose cohort
Read More
Positive preliminary findings from AVR-118 dermatological study
Read More
Canadian approval for Eloxatin in metastatic colorectal cancer
Read More
Algeta and Norwegian Radium Hospital extend cancer research agreement
Read More
AZD-2281 begins phase II trials for breast and ovarian cancers
Read More
BioSante and Pantarhei evaluate new oral contraceptive in phase II trial
Read More
Shire and Renovo sign licensing agreement for Juvista
Read More
IND submission for ALTU-237 in hyperoxalurias
Read More
Pfizer discontinues program for PF-3512676 + cytotoxic chemotherapy
Read More
Approvable letter for maraviroc
Read More
Once-daily Mikelan LA to launch in Japan
Read More
Favorable response by FDA to Epix's Vasovist appeal
Read More
Phase III ENRICH study of Efaproxyn fails to meet primary and secondary endpoints
Read More
Approvable letter for Intuniv in ADHD
Read More
Recent AiCuris and Ranbaxy patents disclose new antiinfective agents
Read More
Final U.S. approval for Exforge
Read More
Recent GSK and Ligand patents report novel therapeutic agents for thrombotic disorders
Read More